Novo Nordisk and Eli Lilly potentially Risking Consumer Health with Ozempic and Mounjaro

Shub & Johns is investigating reports that drugmakers Novo Nordisk and Eli Lilly have manufactured drugs with harmful side effects. These companies produce Ozempic and Mounjaro, drugs that are designed to treat diabetes and promote weight loss. However, it appears that these drugs have the potential for serious side effects, such as gastroparesis, stomach paralysis, and intestinal obstruction.

Companies that produce drugs with potentially serious side effects have a duty to warn consumers about those side effects. This duty to consumers exists so that, when we’re making critical decisions about our health and our bodies, we have the information we need to make the best choice.

At Shub & Johns, we’re alarmed by allegations that Novo Nordisk and Eli Lilly did not adequately warn consumers of the side effects of Ozempic and Mounjaro. Have you taken Ozempic or Mounjaro and experienced side effects? If so, we’d like to hear from you. Please complete the contact form on this page or contact us at 610-477-8380 or info@shublawyers.com.

NOTICE: This website, the related links, and the social media accounts of Shub & Johns LLC contain Attorney Advertising. No aspect of this or any advertisement has been approved by the Supreme Court of Pennsylvania. Shub & Johns’s websites and social media accounts are designed for general information only. The information contained on Shub & Johns’s websites and social media accounts should not be construed as legal advice, should not be relied upon as a substitute for the retention of an attorney or for independent legal research, and does not create an attorney-client relationship. An endorsement of the firm or report of prior results does not guarantee or predict a similar outcome with respect to any future matter.

Novo Nordisk and Eli Lilly potentially Risking Consumer Health with Ozempic and Mounjaro

Have you been affected?Let us know!

Have you been affected?
Let us know!